|
Brenna Jenny, JD, MPH, Deputy Assistant Attorney General, Civil Division, US DOJ to Address the 27th Annual Pharma & Med Device Ethics & Compliance Congress
|
- A Hybrid Onsite Conference and Internet Event
- The Leading Forum on Pharmaceutical and Medical Device Ethics and Compliance Issues
- Sponsored by Pharmaceutical Compliance Forum
- October 13-16, 2026
- Washington Hilton, Washington, DC
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com
|
|
CALL FOR PRESENTATION PROPOSALS CLOSES ON JUNE 12
|
|
Click here to submit a presentation proposal.
|
|
INDIVIDUAL & GROUP REGISTRATION
|
Register by July 17 for Early Bird
Click here to register individuals or groups.
|
|
EXHIBIT & SPONSORSHIP OPPORTUNITIES
|
|
Click here for promotional opportunities.
|
|
|
FEATURING DOJ KEYNOTE ADDRESS BY
|
|

Brenna Jenny, JD, MPH
Deputy Assistant Attorney General, Commercial Litigation Branch, Civil Division, US DOJ; Former Principal Deputy General Counsel & Chief Legal Officer, Centers for Medicare & Medicaid Services, US HHS, Washington, DC |
|
|
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- JUNE 12, 2025: The Twenty-Seventh Annual Pharmaceutical & Medical Device Ethics and Compliance Congress sponsored by the Pharmaceutical Compliance Forum (PCF) will be held at the Washington Hilton, Washington, DC on October 13-16, 2026. Attendees may attend either virtually online or in person. Onsite attendees will also enjoy both live and post-conference access to the Congress audio/video archive.
|
|
THE 2026 27TH ANNUAL CONGRESS FEATURES
|
- New half-day specialty summits on the afternoon of Tuesday 10/13
- Over 50 concurrent mini summits and 15 plenary session presentations
- The PCF-sponsored, Closed-door, invitation-only CCO Roundtable, last year attended by over 100 CCOs
- The Industry-only Compliance Best Practices Think Tank hosted by PCF
- A sold-out exhibit hall featuring many innovative ethics and compliance products, programs and initiatives
- Numerous professional networking opportunities
|
FEATURED ETHICS & COMPLIANCE PROFESSIONALS AND IN-HOUSE COUNSEL
|

Peter Brensilver, JD, MPH
Senior Vice President, Chief Global Commercial Compliance & Risk Counsel, Pfizer, New York, NY |

Terra Buckley, JD
Chief Compliance & Ethics Officer, Bristol Myers Squibb; Former CCO, LivaNova, Summit, NJ |

Briana Cabrera, MS, CFE
Senior Director, Global Privacy & Compliance Investigations, Medtronic; Former Director, Forensic Audit, Covidien, Miami, FL
|

Regina Cavaliere, JD
Chief Ethics & Compliance Officer, VP Regulatory & Compliance, Henry Schein, Melville, NY |

Kevin Espinoza, MBA
Chief Integrity & Compliance Officer, Indivior; Former Chief Integrity & Compliance Officer, Kaleo; Former Senior VP, Boston Scientific, Richmond, VA |

Yelena Ferreira, JD
Assistant GC & Head of Compliance, Pharmacosmos; Former Senior Director, Associate General Counsel, Pacira, Morristown, NJ
|

Lindsey LaMoria Gavin
Senior Director, Deputy Compliance Officer, Lundbeck; Former Compliance Director, Meetings & Events International, Deerfield, IL |

Kate Godfrey, JD, CCEP
Senior Vice President, Global Chief Compliance Officer, Chief Compliance Officer KSNA, Karl Storz North America, El Segundo, CA |

Abe Kassis, MBA, PhD
Global Head Compliance & Legal Operations, Bausch + Lomb; Former Global Compliance Director, Takeda, New York, NY
|

Jeffrey Kawalek, MBA
Chief Compliance Officer, Zambon US; Former Deputy CCO US, Jazz; Former Co-chair, PCF, New York, NY |

Cheryl Lee, MBA, CHC
Head of Compliance, Cycle; Former VP, ESG Strategy & Execution, BMS; Former VP, Head of Compliance Worldwide Markets, Celgene, New York, NY |

Peter Lee, JD, LLM
Chief Compliance Officer, Kura Oncology; Former CCO, Mirati Therapeutics; Former CCO, Heron Therapeutics, San Diego, CA
|

Melissa T. Lozner, JD
Senior VP, CCO, Regeneron; Former Chief Compliance & Ethics Officer, Rafael Holdings; Former VP, Head of Ethics, Risk & Compliance, Novartis, Tarrytown, NY |

Joan Podleski, CCEP, CHPC, CHRC, CHC
VP & CPO, Children's Health System of Texas; Former Director, Institutional Ethics & Compliance Program, Duke University, Dallas, TX |

Ariadna Quesada, MSJ
VP, Compliance, Global Compliance & Privacy lead, ZOLL Medical; Former Compliance Director, Europe & MEATI, Hillrom, Madrid, Spain
|

R. Brett Short, CHC, CHPC, CHRC
CCO & CPO, University of Kentucky; Immediate Past Chair, Health Care Compliance Association, Lexington, KY |

Ronald Strauss, CIPM
Vice President Compliance, MiMedx; Former Executive Sales Representative, Eli Lilly Specialty, Marietta, GA |

Betsy Wade, MPH, CHC, CHPC, CAN
Chief Compliance & Ethics Officer, Signature Healthcare; Board & Treasurer, Health Care Compliance Association, Louisville, KY
|

Kelly Willenberg, MBA, DBA, CHC, CHRC
Chief Executive Officer, Kelly Willenberg & Assocs.; Board & Second Vice Chair, Health Care Compliance Association, Greenville, SC |

Amy Wilson, MBA, MSJ
VP & CCO, Esperion; Former Head of US Compliance, MorphoSys; Former Director, Enterprise Compliance, Alexion, Boston, MA |

Stacy E. Yeung, JD
VP & GC, SELLAS; Former Assistant General Counsel, Arena Pharmaceuticals; Former Deputy General Counsel, DBV Technologies, New York, NY
|
|
FORMER GOVERNMENT OFFICIALS
|

Corey R. Amundson, JD
Partner, King & Spalding; Former Head, Public Integrity Section, US DOJ; Former Acting US Attorney, Middle District of Louisiana, Washington, DC |

Jennifer L. Bragg, JD
Partner, Latham and Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC |

Hui Chen, JD
Co-Founder, Culture. Data. Ethics; Former Compliance Counsel Expert, US DOJ; Former Assistant General Counsel, Pfizer, Honolulu, HI
|

Deborah A. Curtis, JD
Partner, Arnold & Porter; Former Deputy GC, CIA; Former Deputy Chief, Counterespionage, US DOJ, Washington, DC |

John Delacourt, JD
Deputy GC, VP Health, Regulatory & Commercial Operations, BIO; Former Chief Antitrust Counsel, FTC, Washington, DC |

Greg Demske, JD
Partner, Goodwin Procter; Former Chief Counsel, Office of Inspector General, US HHS, Washington, DC
|

Sarah A. Franklin, JD
Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling; Former Attorney, US FTC, Washington, DC |

Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC |

John Kelly, JD
Partner & Chair, Healthcare Practice, Barnes & Thornburg; Former Asst. Chief for Health Care Fraud, Criminal Division, US DOJ, Washington, DC
|

Barbara A. Leaf, JD
Senior International Policy Advisor, Arnold & Porter; Former Special Assistant to the President; Former US Ambassador, UAE, Washington, DC |

Michael L. Shaw, JD
Global Head of Compliance, Privacy and Risk, ZS; Former VP & CO, GlaxoSmithKline; Former Senior Counsel, OIG US HHS, Princeton, NJ |

Jane H. Yoon, JD
Partner, Litigation Department, Paul Hastings; Former Assistant United States Attorney, US Attorney's Office for the District of New Jersey, New York, NY
|
|
OTHER FEATURED FACULTY
|

Eliza L. Andonova, JD
Partner, Global Regulatory, Hogan Lovells, Washington, DC |

Samantha Barrett Badlam, JD
Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC |

Yogesh Bahl, MBA
Practice Leader, Resolution Life Sciences; CFO & Head of Investor Relations, IACTA, New York, NY
|

Craig B. Bleifer, JD
Partner, McGuire Woods; Former Corporate VP, GC North America; Novo Nordisk, New York, NY |

Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC |

Jennifer Ceglinski, JD, CFE
Manager, Forensic & Integrity Services, EY, Charlotte, NC
|

Benjamin Correa, JD
Partner, Food, Drug & Medical Device, Sidley Austin, Washington, DC |

Zachary Coseglia, JD
Co-Founder, Culture. Data. Ethics; Former VP & AGC, Monitoring, Analytics and Digital, Pfizer, Boston, MA |

Layla Covington, JD
Senior Manager, Compliance Consulting, Cresen; Former Manager, Aggregate Spend, Genentech, Chicago, IL
|

Clarissa Crain
Managing Director, Deloitte, Phoenixville, PA |

Meena Datta, JD
Partner and Global Co-leader, Healthcare Practice, Sidley Austin, Chicago, IL |

Mahnu V. Davar, MA, JD
Partner and Co-chair, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC
|

Stefanie A. Doebler, JD
Partner and Co-Chair, Health Care Practice Group, Covington & Burling, Washington, DC |

Kip Ebel, MBA
Principal, Forensic & Integrity Services, EY, New York, NY |

Aurelie Ercoli, LLM, PhD
Partner, Life Sciences Practice Group, DLA Piper, US, Washington, DC
|

Ronnie H. Feldman
Founder & CEO, L&E: Comedians Who Improve Compliance, Chicago, IL |

David Fisher, MS
President, TDI Solutions; Former VP & General Manager, Cyber Innovations, Battelle, Washington, DC |

Sara K. Frank, JD
Principal, Life Science Practice, Choate Hall & Stewart, Boston, MA
|

Gary F. Giampetruzzi, JD
Partner & Global Chair Life Sciences, Paul Hastings; Former VP & AGC, Head of Government Investigations, Pfizer, New York, NY |

Neeraj Gupta, MBA
President, Chief Technology Officer, Cresen Solutions, Chester Springs, PA |

Kris Hall, JD, CIPP/CIPM
Managing Director, Dovetail; Former VP, Chief Privacy Officer, Celgene; Former VP, Head of Privacy, Shire, Bridgton, ME
|

Kristin M. Hicks, JD
Partner, Arnold & Porter, Washington, DC |

Emily F. Hodge, JD
Partner, Life Science Practice, Choate, Hall & Stewart, Boston, MA |

Casey J. Horton, CFE
Managing Director, Epsilon Life Sciences; Former Director, Compliance Operations, AbbVie, Chicago, IL
|

Mark A. Jensen, JD
Partner, Special Matters and Government Investigations, King & Spalding, Washington, DC |

Erin Brown Jones, MA, JD
Partner, Latham & Watkins, Washington, DC |

Olivia Krzeminski, JD
Director of Compliance & Legal Research, G&M Health, Somerset, NJ
|

Jeffrey Low, RPh, MHA
Director, Ankura; Former VP, Clinical Services, Magellan Health; Former Director, Medicare Services, CVS/Caremark, Phoenix, AZ |

Robert Melillo, JD
Co-founder and Managing Director, G&M Health, Cocoa Beach, FL |

Brook Mishler, RN, MSN
Global Director of Compliance Solutions, Life Sciences, Case IQ; Former Compliance Officer for the Americas, Cordis, Ontario, Canada
|

Katherine C. Norris, MPA
Senior Managing Director, Life Sciences Compliance, Disputes & Economics, Ankura, Honolulu, HI |

Daniel O'Connor
Senior Vice President, NXLevel Compliance; Angel Investor, Angel Investor Forum, Lambertville, NJ |

Saraswatha Lalitha Putcha
Director, Product & Client Delivery, Cresen Solutions, Philadelphia, PA
|

Nikki Reeves, JD
Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC |

Russell Rose, JD
Managing Director, Life Sciences Advisory, Deloitte, Dallas, TX |

Jeffrey Scott, JD
Of Counsel, Life Sciences, DLA Piper; Former Lead Compliance Counsel, Digital, Reporting, and Analytics, Pfizer, Philadelphia, PA
|

Paul Silver
Principal, Life Sciences Regulatory, Legal & Compliance Leader, Deloitte, Atlanta, GA |

L. Stephan Vincze, JD, LLM, MBA
President & CEO, TRESTLE Compliance; Former SVP & CCO, Warner Chilcot; Former VP & CCO, TAP, Boston, MA |

Shannon Walker
Executive Vice President, Thought Leadership & Strategy, Case IQ; Founder and President, Whistleblower Security, Ontario, Canada
|

Robert A. Wells, JD
Shareholder, Baker Donelson, Baltimore, MD |

Kelly Willenberg, MBA, DBA, CHC
Chief Executive Officer, Kelly Willenberg and Associates, Greenville, SC |

Cobun Zweifel-Keegan, JD, CIPP/US
Managing Director, IAPP; Former Deputy Director, Privacy Initiatives, Better Business Bureau, Washington, DC
|
|
THE PHARMA CONGRESS ANNOUNCES AN EXTRA AFTERNOON OR HALF-DAY SPECIALTY FOCUSED SESSIONS ON HIT ISSUES IN PHARMA & DEVICE COMPLIANCE!
|
|
Kick off 27th Pharma/Device Ethics & Compliance Congress with an added half-day of high-impact Specialty Sessions on Tuesday afternoon, October 13, featuring timely, expert-led deep dives on the hottest issues facing pharma and device companies today. These will include sessions on Advanced Strategies Coordinating Compliance between Medial Affairs and Commercial & Practical Case Studies in the Use of AI by Pharma and Device Company Ethics and Compliance Departments. Included with your registration, this is a valuable opportunity to gain practical insights, benchmark with peers, and arrive fully prepared for the main three-day event.
|
|

|
|
SPONSORED BY
|

|
|
PRODUCED BY
|

|
|
PCF BOARD
|

Donna White, CCEP
Vice President and Compliance Officer, Chiesi Farmaceutici S.p.A., Americas Region (Board Chair)

Christie Camelio
Senior Vice President and Chief Compliance Officer, Insmed

Jill Dailey, JD
Vice President & Chief Compliance Officer, Oncology, Menarini Stemline

Anisa Dhalla
Vice President, Global Head, Ethics and Business Integrity, UCB

Daryl Kreml, JD
Head of Ethics & Compliance, Global Oncology, Takeda

Melissa T. Lozner, JD
Senior Vice President, Chief Compliance Officer, Regeneron
|
|
MEDICAL DEVICE EXECUTIVE COMMITTEE
|

Sujata Dayal, JD
Independent Board Director, Emergent BioSolutions; Senior Advisor

JJ Kuhn, JD
Senior Vice President and Chief Ethics & Compliance Officer, Solventum

Mona Peterson Rosow, JD, MPH
Vice President, Global Risk, Ethics & Compliance Officer, Mozarc Medical

Tara Shewchuk, JD, LLM
Senior Vice President, Chief Privacy, Integrity & Compliance Officer, Medtronic

Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker
|
|
MEDIA PARTNERS
|


|
|
GRANTORS
|
|
PLATINUM
|

|
|
GOLD
|





|
|
SILVER
|











|
|
BRONZE
|





















|
|
EXHIBITOR
|

|
|
|
AN OVERVIEW OF THE 27TH CONGRESS SCHEDULE
|
Day 1: Tuesday, October 13,2026
- Afternoon Half-day Specialty Focused Sessions
Day 2: Wednesday, October 14,2026
- Networking Breakfast
- Morning Concurrent Mini Summits
- Networking Luncheon
- Afternoon Opening Plenary Session
- Networking Reception
Day 3: Thursday, October 15,2026
- Networking Breakfast
- Morning PCF CCO Roundtable (Invitation-only)
- Morning Concurrent Mini Summits
- Networking Luncheon
- Afternoon Closing Plenary Session
Day 4: Friday, October 16,2026
- Networking Breakfast
- Morning PCF Industry-only Plenary Session
- Noon: Congress Adjournment
|
|
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
|
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.
For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.
|
|
|
|
|